Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/168549
Title: | Urinary biomarkers for the detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia |
Author: | Sequeiros, Tamara Bastarós, Juan M. Sánchez, Milagros Rigau, Marina Montes, Melania Placer, José Planas, Jacques Torres, Inés de Reventós Puigjaner, Jaume Pegtel, D. Michiel Doll, Andreas Morote, Juan Olivan Riera, Mireia |
Keywords: | Indicadors biològics Càncer Orina Indicators (Biology) Cancer Urine |
Issue Date: | 1-Jul-2015 |
Publisher: | Wiley |
Abstract: | Introduction: high-grade prostatic intraepithelial neoplasia (HGPIN) is a recognized precursor stage of PCa. Men who present HGPIN in a first prostate biopsy face years of active surveillance including repeat biopsies. This study aimed to identify non-invasive prognostic biomarkers that differentiate early on between indolent HGPIN cases and those that will transform into actual PCa. Methods: we measured the expression of 21 candidate mRNA biomarkers using quantitative PCR in urine sediment samples from a cohort of 90 patients with initial diagnosis of HGPIN and a posterior follow up of at least two years. Uni- and multivariate statistical analyses were applied to analyze the candidate biomarkers and multiplex models using combinations of these biomarkers. Results: PSMA, PCA3, PSGR, GOLM, KLK3, CDH1, and SPINK1 behavedas predictors for PCa presence in repeat biopsies. Multiplex models outperformed (AUC = 0.81-0.86) the predictive power of single genes, including the FDA-approved PCA3 (AUC = 0.70). With a fixed sensitivity of 95%, the specificity of our multiplex models was of 41-58%, compared to the 30% of PCA3. The PPV of our models (30-38%) was also higher than the PPV of PCA3 (27%), suggesting that benign cases could be more accurately identified. Applying statistical models, we estimated that 33% to 47% of repeat biopsies could be prevented with a multiplex PCR model, representing an easy applicable and significant advantage over the current gold standard in urine sediment. Discussion: using multiplex RTqPCR-based models in urine sediment it is possible to improve the current diagnostic method of choice (PCA3) to differentiate between benign HGPIN and PCa cases. |
Note: | Versió postprint del document publicat a: https://doi.org/10.1002/pros.22995 |
It is part of: | Prostate, 2015, vol. 75, num. 10, p. 1102-1113 |
URI: | http://hdl.handle.net/2445/168549 |
Related resource: | https://doi.org/10.1002/pros.22995 |
ISSN: | 0270-4137 |
Appears in Collections: | Articles publicats en revistes (Patologia i Terapèutica Experimental) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
700407.pdf | 538.43 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.